Comparison of the effects of gonadotropin-releasing hormone and raloxifeneon the size of uterine leiomyoma
Journal Title: Chronic Diseases Journal - Year 2014, Vol 2, Issue 1
Abstract
BACKGROUND: Uterine leiomyoma is a prevalent benign tumor. Several studies have shown the positive effects of raloxifene in the treatment of leiomyomas. Since raloxifene has fewer side effects than the gonadotropin-releasing hormone (GnRH) agonist, if proven effective, it can be applied easily. This study aimed to compare the medical effects of raloxifene and GnRH on uterine leiomyoma size. METHODS: This clinical trial included 53 women with uterine leiomyoma. Participants were randomly divided into 2 groups of raloxifene and GnRH. The GnRH group received 1 dose per month (intramuscular injection) and the raloxifene group received 60 mg raloxifene orally/day for 3 months. The size of the leiomyoma, prior and during the intervention, was determined by a sonographist. During the study, repeated measurement was used for comparing the trend of alterations in the tumor size. RESULTS: Analysis of changes in leiomyoma tumor size (log of tumor size) by repeated measurement showed that decrease in tumor size in the raloxifene group was significantly higher than GnRH group (P = 0.042). The trends of changes in endometrial thickness were different in the 2 groups and the reduction of thickness was more significant in the GnRH group (P = 0.026). CONCLUSION: This study showed that raloxifene is an appropriate medicine to reduce the size of uterine leiomyoma and is more effective than GnRH.
Authors and Affiliations
Farnaz Zandvakili, Fariba Seyedoshohadaie, Masoumeh Rezaiee, Nasrin Soofizade, Ebrahim Ghaderi
A clinical study of the effect of Glycyrrhiza glabra plant and exercise on the quality of life of menopausal women
BACKGROUND: Most women experience significant changes during and after menopause which causes various complications of menopause and the changes in quality of their life. The aim of this study was to evaluate the effect...
The effect of amniotic membrane on growth, proliferation, and survival of the myeloma cells and examination of genes related to proliferation (BCL2), implantation (CXCR4), and cell cycle stop (P21 and P27)
BACKGROUND: The myeloma cell is not able to grow and proliferate out of bone marrow (BM) media, and in laboratory conditions its survival is low. We considered to use an environment that has the same conditions as body p...
The effects of Tranquival tablet on some heroin withdrawal symptoms
BACKGROUND: Individuals, during opioid withdrawal period, experience symptoms such as dysphoria, insomnia, anxiety, irritability, nausea, agitation, tachycardia, and hypertension which may trigger drug seeking behavior a...
Investigating the relationship between the level of serum albumin and body mass index, as nutritional indicators, with dialysis adequacy in patients under hemodialysis
BACKGROUND: Patients with end-stage renal disease (ESRD) who undergo hemodialysis have many complications; one of the most important of which is malnutrition, which affects these patients’ quality of life. The aim of thi...
Report of the clinical features of patients with leptospirosis in Golestan, Iran, 2011-2015: Based on information available at the provincial health center
BACKGROUND: Leptospirosis is a zoonotic disease with a global distribution that is caused by pathogenic spirochetes of Leptospira. It has a global spread, but it is more common in warm and tropical regions. In developing...